A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome

Eur J Haematol. 2006 May;76(5):432-5, 453. doi: 10.1111/j.1600-0609.2006.00628.x. Epub 2006 Feb 15.

Abstract

We describe a patient with acquired alpha-thalassemia myelodysplastic syndrome (ATMDS). A previously healthy 66-year-old man presented with hemoglobin of 9.3 g/dL, mean corpuscular volume 59 fL, and a bone marrow aspirate with increased erythroid precursors and hypolobulated megakaryocytes. Hemoglobin H inclusions were seen in most red cells after 1% brilliant cresyl blue supravital stain of the peripheral blood. At the molecular level, we identified of a novel mutation in the most 3' exon of the ATRX gene (CGA-->TGA substitution in codon 2407) resulting in a premature termination codon (p.R2407X). This case provides further evidence for a link between ATRX mutations and ATMDS, and suggests a possible role for the conserved Q-box element in ATRX function.

Publication types

  • Case Reports
  • Comparative Study

MeSH terms

  • Aged
  • DNA Helicases / genetics*
  • Exons
  • Humans
  • Male
  • Molecular Sequence Data
  • Myelodysplastic Syndromes / genetics*
  • Nuclear Proteins / genetics*
  • Point Mutation*
  • X-linked Nuclear Protein
  • alpha-Thalassemia / genetics*

Substances

  • Nuclear Proteins
  • DNA Helicases
  • ATRX protein, human
  • X-linked Nuclear Protein

Associated data

  • RefSeq/NM_000489
  • RefSeq/NP_000480